Abstract
Apicomplexan parasites are responsible for a myriad of diseases in humans and livestock; yet despite intensive effort, development of effective sub-unit vaccines remains a long-term goal. Antigenic complexity and our inability to identify protective antigens from the pool that induce response are serious challenges in the development of new vaccines. Using a combination of parasite genetics and selective barriers with population-based genetic fingerprinting, we have identified that immunity against the most important apicomplexan parasite of livestock (Eimeria spp.) was targeted against a few discrete regions of the genome. Herein we report the identification of six genomic regions and, within two of those loci, the identification of true protective antigens that confer immunity as sub-unit vaccines. The first of these is an Eimeria maxima homologue of apical membrane antigen-1 (AMA-1) and the second is a previously uncharacterised gene that we have termed ‘immune mapped protein-1’ (IMP-1). Significantly, homologues of the AMA-1 antigen are protective with a range of apicomplexan parasites including Plasmodium spp., which suggest that there may be some characteristic(s) of protective antigens shared across this diverse group of parasites. Interestingly, homologues of the IMP-1 antigen, which is protective against E. maxima infection, can be identified in Toxoplasma gondii and Neospora caninum. Overall, this study documents the discovery of novel protective antigens using a population-based genetic mapping approach allied with a protection-based screen of candidate genes. The identification of AMA-1 and IMP-1 represents a substantial step towards development of an effective anti-eimerian sub-unit vaccine and raises the possibility of identification of novel antigens for other apicomplexan parasites. Moreover, validation of the parasite genetics approach to identify effective antigens supports its adoption in other parasite systems where legitimate protective antigen identification is difficult.
Highlights
The protozoan phylum Apicomplexa contains pathogens of substantial medical and veterinary importance including Plasmodium, Toxoplasma, Cryptosporidium, Eimeria, Neospora and Theileria species
This study represents the culmination of work using parasite genetics and immunity as a selective barrier to find parts of the parasite genome targeted by immunity
The pathogen used in these studies (Eimeria maxima) is very important in livestock and related to a number of human pathogens including those responsible for malaria
Summary
The protozoan phylum Apicomplexa contains pathogens of substantial medical and veterinary importance including Plasmodium, Toxoplasma, Cryptosporidium, Eimeria, Neospora and Theileria species. We report the culmination of our efforts to develop a new approach to candidate antigen identification, one based upon using immunity as a selective barrier allied with pathogen genetics and mapping to identify true immune-targeted loci. Having identified candidate genomic regions we used a variety of strategies to locate the antigen responsible for protection. This approach has yielded new protective antigens for Eimeria maxima, one of the most important apicomplexan parasites to afflict livestock and provides insight into the nature of protective antigens in a broader context. Eimeria species parasites have a globally enzootic distribution and can cause severe enteric disease in all livestock, most notably poultry, where the annual cost is estimated to exceed £2 billion worldwide [5]. Different strains of E. maxima can be antigenically diverse such that infection by one strain can induce little or no protection against
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
